•
Dec 31, 2016

Jazz Pharmaceuticals Q4 2016 Earnings Report

Total Revenue
$397M
Previous year: $341M
+16.4%
EPS
$2.71
Previous year: $2.6
+4.2%
Gross Profit
$363M
Previous year: $317M
+14.6%
Cash and Equivalents
$366M
Previous year: $989M
-63.0%
Total Assets
$4.8B
Previous year: $3.33B
+44.0%

Jazz Pharmaceuticals

Jazz Pharmaceuticals